Will the FDA approve any psychedelic substance for medical use before 2027? | PredictPedia

Events

GroupKALSHI

Event GroupKALSHIHealth

Will the FDA approve any psychedelic substance for medical use before 2027?

Total Volume

$40.95K

Events

Markets

Trade on Kalshi

Will the FDA approve any psychedelic substance for medical use before 2027?

Platform StatsQuick Platform Comparison

Polymarket

markets · $0.00

Kalshi

markets · $40.95K

Price Spread

0.0%avg

max 0.0%

Arbitrage

of 0 cross-platform

Volume DistributionTotal: $40.95K

100%

Kalshi leads

Price ChartMatched Markets Price Graph

1 market tracked

Will the FDA approve Any psychedelic substance for medical use this year?

No data available

Single-Platform Markets(1)

Market	Platform	Price
Will the FDA approve Any psychedelic substance for medical use this year?	Kalshi	40%

AI Analysis

Trader mode: Actionable analysis for identifying opportunities and edge

40%

Top Probability

$40.95K

Volume

Markets

Platforms

About This Event

Before 2027 If the FDA approves Any psychedelic substance for medical use for marketing before Jan 1, 2027, then the market resolves to Yes. Psychedelic drugs include: LSD, Psilocybin, DMT, Mescaline, MDMA, MDA,, PCP, DXM, Ibogaine, Salvia divinorum, 2C family, and Ayahuasca. This market will close and expire early if the event occurs.

AI-generated analysis based on market data. Not financial advice.

Custom AI Analysis Prompt

Tap to expand

Open in:ChatGPT Claude Gemini Grok DeepSeek

**Role:** Expert Prediction Market Analyst & Trader
**Objective:** Analyze the provided betting market data to deliver actionable insights, identify mispricings, and perform scenario analysis.
**Current Date:** Friday, January 16, 2026
**Context:** Prediction markets (Polymarket/Kalshi) are binary option markets where price (1-99) equals implied probability (1%-99%).

---

## 1. Event Snapshot
**Event:** Will the FDA approve any psychedelic substance for medical use before 2027?
**Category:** Health | **Status:** active
**Resolution Date:** N/A (Unknown)
**Time Pressure:** Unknown

**Description:** Before 2027

If the FDA approves Any psychedelic substance for medical use for marketing before Jan 1, 2027, then the market resolves to Yes. Psychedelic drugs include: LSD, Psilocybin, DMT, Mescaline, MDMA, MDA,, PCP, DXM, Ibogaine, Salvia divinorum, 2C family, and Ayahuasca. This market will close and expire early if the event occurs.

**Resolution Criteria (Sample):**
"If the FDA approves Any psychedelic substance for medical use for marketing before Jan 1, 2027, then the market resolves to Yes. Secondary rules: Psychedelic drugs include: LSD, Psilocybin, DMT, Mescaline, MDMA, MDA,, PCP, DXM, Ibogaine, Salvia divinorum, 2C family, and Ayahuasca. Early close condit"

## 2. Market liquidity & Volume
* **Total Volume:** $40.9K
* **Total Liquidity:** $3.40M
* **Activity Level:** Low Activity (Vol/Liq Ratio: 0.01)

## 3. Market Data (Prices & Odds)
### 1. Will the FDA approve Any psychedelic substance for medical use this year?
- **Kalshi** (End: Jan 8, 2027): Vol $40.9K
  DATA: [Yes: 39.5% (0.0%)] | [No: 60.5% (0.0%)]

---

## Analysis Instructions
Please provide a structured analysis using the following template:

### 1. Executive Summary
*   **Verdict:** [Most Likely Outcome]
*   **Confidence:** [0-100]%
*   **Timeframe:** [Immediate / Short-term / Long-term]
*   **Actionable Trade:** [Buy YES / Buy NO / Stay Away] (Include entry price target if applicable)
*   **Rationale:** 2-sentence summary of the core thesis.

### 2. Scenario Analysis
*   **Bull Case (Why YES goes up):** List specific catalysts or data points.
*   **Bear Case (Why YES goes down):** List specifics.
*   **Invalidation Point:** What happens to prove your thesis wrong?

### 3. Market Mechanics & Risks
*   **Liquidity/Volume Analysis:** Is the market efficient? Is it easy to exit?
*   **Cross-Platform Arbitrage:** (If applicable) Is the spread tradeable after fees?
*   **Time Decay:** How does time passing affect this position?

### 4. Signal Scores (0-100)
*   **Momentum:** [Score] (Price trend & velocity)
*   **Conviction:** [Score] (Volume backing the move)
*   **Information Edge:** [Score] (Likelihood of non-public info affecting price)
*   **Risk/Reward:** [Score] (Potential upside vs downside)

**Constraints:**
- Be direct and objective.
- Use bullet points for readability.
- If data is conflicting or insufficient, explicitly state "Low Confidence".

Tap text to select all

Market Insights

Average Yes Price

40¢

Kalshi

Arbitrage Opps

Cross-Platform

Embed Widget

Add this market to your website

Volume

Platforms

HTML

<iframe src="https://predictpedia.com/embed/R9HxBe" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="Will the FDA approve any psychedelic substance for medical use before 2027?"></iframe>

Trade This Market

Trade on Kalshi

Will the FDA approve any psychedelic substance for medical use before 2027?

Will the FDA approve any psychedelic substance for medical use before 2027?

Platform StatsQuick Platform Comparison

Price ChartMatched Markets Price Graph

Will the FDA approve Any psychedelic substance for medical use this year?

AI Analysis

About This Event

Custom AI Analysis Prompt

Custom AI Analysis Prompt

Educational Context

Events (1)